Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer.
Rosell, R
Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer. [electronic resource] - Seminars in oncology Aug 2001 - 37-44 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0093-7754
10.1016/s0093-7754(01)90058-2 doi
Antineoplastic Agents--pharmacology
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carboplatin--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials as Topic
DNA, Neoplasm--blood
Drug Evaluation, Preclinical
Drug Resistance, Neoplasm
Humans
Lung Neoplasms--drug therapy
Paclitaxel--administration & dosage
Tubulin--genetics
Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer. [electronic resource] - Seminars in oncology Aug 2001 - 37-44 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0093-7754
10.1016/s0093-7754(01)90058-2 doi
Antineoplastic Agents--pharmacology
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carboplatin--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials as Topic
DNA, Neoplasm--blood
Drug Evaluation, Preclinical
Drug Resistance, Neoplasm
Humans
Lung Neoplasms--drug therapy
Paclitaxel--administration & dosage
Tubulin--genetics